Related references
Note: Only part of the references are listed.Inflammation-dependent overexpression of c-Myc enhances CRL4(DCAF4) E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer
Hong Liu et al.
JOURNAL OF PATHOLOGY (2019)
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
Ashley V. Menk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
A selective high affinity MYC-binding compound inhibits MYC: MAX interaction and MYC-dependent tumor cell proliferation
Alina Castell et al.
SCIENTIFIC REPORTS (2018)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
Chetasi Talati et al.
SEMINARS IN HEMATOLOGY (2017)
Regulators of Glucose Metabolism in CD4+ and CD8+ T Cells
Clovis S. Palmer et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2016)
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
R. Gopalakrishnan et al.
ONCOGENE (2016)
Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer
Shima Nakanishi et al.
AMINO ACIDS (2016)
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Michael D. Buck et al.
CELL (2016)
Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells
Angelika Broer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation
Hung D. Nguyen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon
T. Van Nguyen et al.
MOLECULAR CELL (2016)
Metabolic maintenance of cell asymmetry following division in activated T lymphocytes
Katherine C. Verbist et al.
NATURE (2016)
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Georg Petzold et al.
NATURE (2016)
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation
Kristen N. Pollizzi et al.
NATURE IMMUNOLOGY (2016)
Emerging concepts of T cell metabolism as a target of immunotherapy
Chih-Hao Chang et al.
NATURE IMMUNOLOGY (2016)
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity
Ruth Eichner et al.
NATURE MEDICINE (2016)
Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation
Jung-Ah Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Impaired CD98 signaling protects against graft-versus-host disease by increasing regulatory T cells
Yoshiaki Nishio et al.
TRANSPLANT IMMUNOLOGY (2016)
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Patrick R. Hagner et al.
BLOOD (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
T-bet Is Critical for the Development of Acute Graft-versus-Host Disease through Controlling T Cell Differentiation and Function
Jianing Fu et al.
JOURNAL OF IMMUNOLOGY (2015)
Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation
Shivtia Trop-Steinberg et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2015)
Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation
Melissa Alsina et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Ikaros Imposes a Barrier to CD8+ T Cell Differentiation by Restricting Autocrine IL-2 Production
Shaun O'Brien et al.
JOURNAL OF IMMUNOLOGY (2014)
Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer et al.
NATURE (2014)
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P. Chamberlain et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease
Gary D. Glick et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner
Takero Shindo et al.
BLOOD (2013)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Behavioral characterization of cereblon forebrain-specific conditional null mice: A model for human non-syndromic intellectual disability
Anjali M. Rajadhyaksha et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
Jessica L. Allen et al.
BLOOD (2012)
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yibin Yang et al.
CANCER CELL (2012)
Translation Regulation as a Therapeutic Target in Cancer
Michal Grzmil et al.
CANCER RESEARCH (2012)
The dynamic regulation of NAD metabolism in mitochondria
Liana Roberts Stein et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Functional modulation of AMP-activated protein kinase by cereblon
Kwang Min Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
Ruoning Wang et al.
IMMUNITY (2011)
Loss of T Cell CD98 H Chain Specifically Ablates T Cell Clonal Expansion and Protects from Autoimmunity
Joseph Cantor et al.
JOURNAL OF IMMUNOLOGY (2011)
Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells
Seung H. Choi et al.
GENES & DEVELOPMENT (2010)
The metabolic life and times of a T-cell
Ryan D. Michalek et al.
IMMUNOLOGICAL REVIEWS (2010)
In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization
Dana M. Clausen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
PKC theta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice
Javier O. Valenzuela et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Anergic T Cells Are Metabolically Anergic
Yan Zheng et al.
JOURNAL OF IMMUNOLOGY (2009)
Memory-Like CD8+ T Cells Generated during Homeostatic Proliferation Defer to Antigen-Experienced Memory Cells
Kitty P. Cheung et al.
JOURNAL OF IMMUNOLOGY (2009)
Polyamines Regulate c-Myc Translation through Chk2-dependent HuR Phosphorylation
Lan Liu et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
Sydney X. Lu et al.
BLOOD (2008)
MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation
Yair Dorsett et al.
IMMUNITY (2008)
Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation
Joseph J. Higgins et al.
NEUROGENETICS (2008)
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Meletios Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Donna M. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase II study
Asher Chanan-Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Role of polyamines derived from arginine in differentiation and proliferation of human blood cells
T Maeda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo
I Messaoudi et al.
JOURNAL OF IMMUNOLOGY (2006)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation
JA Nilsson et al.
CANCER CELL (2005)
Molecular cloning, characterization, and chromosomal assignment of porcine cationic amino acid transporter-1
ZQ Cui et al.
GENOMICS (2005)
Efficacy of lenalidomide in myelodysplastic syndromes
A List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain
S Jo et al.
JOURNAL OF NEUROCHEMISTRY (2005)
A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation
JJ Higgins et al.
NEUROLOGY (2004)
Antibody specific for the peptide•major histocompatibility complex -: Is it T cell receptor-like?
T Mareeva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antigen-driven effector CD8 T cell function regulated by T-bet
BM Sullivan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The CD8α gene locus is regulated by the Ikaros family of proteins
N Harker et al.
MOLECULAR CELL (2002)
ZAP-70-independent Ca2+ mobilization and Erk activation in Jurkat T cells in response to T-Cell antigen receptor ligation
XC Shan et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB
JQ Clement et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
